Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14
Kestra Medical Technologies (Nasdaq: KMTS), a wearable medical device and digital healthcare company, has scheduled its third quarter fiscal 2025 financial results announcement for Monday, April 14. The company will host a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time to discuss the results. Investors can access both live and archived versions of the webcast through the 'Events' section of the investor relations website, with registration recommended at least 10 minutes before the call.
Kestra Medical Technologies (Nasdaq: KMTS), un'azienda che si occupa di dispositivi medici indossabili e di sanità digitale, ha programmato l'annuncio dei risultati finanziari per il terzo trimestre dell'anno fiscale 2025 per lunedì 14 aprile. L'azienda ospiterà una conferenza telefonica alle 16:30 ora orientale / 13:30 ora del Pacifico per discutere i risultati. Gli investitori possono accedere sia alla versione in diretta che a quella archiviata del webcast attraverso la sezione 'Eventi' del sito web delle relazioni con gli investitori, con registrazione consigliata almeno 10 minuti prima della chiamata.
Kestra Medical Technologies (Nasdaq: KMTS), una empresa de dispositivos médicos portátiles y atención sanitaria digital, ha programado el anuncio de sus resultados financieros para el tercer trimestre del año fiscal 2025 para el lunes 14 de abril. La empresa llevará a cabo una conferencia telefónica a las 4:30 p.m. hora del Este / 1:30 p.m. hora del Pacífico para discutir los resultados. Los inversores pueden acceder tanto a la versión en vivo como a la archivada de la transmisión a través de la sección 'Eventos' del sitio web de relaciones con inversores, siendo recomendable registrarse al menos 10 minutos antes de la llamada.
Kestra Medical Technologies (Nasdaq: KMTS), 착용 가능한 의료 기기 및 디지털 헬스케어 회사는 2025 회계연도 3분기 재무 결과 발표를 4월 14일 월요일로 예정했습니다. 회사는 동부 표준시 오후 4:30 / 태평양 표준시 오후 1:30에 결과를 논의하기 위한 전화 회의를 주최할 것입니다. 투자자는 투자자 관계 웹사이트의 '이벤트' 섹션을 통해 실시간 및 아카이브된 웹캐스트 버전에 접근할 수 있으며, 통화 10분 전까지 등록하는 것이 권장됩니다.
Kestra Medical Technologies (Nasdaq: KMTS), une entreprise de dispositifs médicaux portables et de santé numérique, a programmé l'annonce de ses résultats financiers pour le troisième trimestre de l'exercice 2025 pour lundi 14 avril. L'entreprise organisera une conférence téléphonique à 16h30 heure de l'Est / 13h30 heure du Pacifique pour discuter des résultats. Les investisseurs peuvent accéder aux versions en direct et archivées du webinaire via la section 'Événements' du site Web des relations avec les investisseurs, avec une inscription recommandée au moins 10 minutes avant l'appel.
Kestra Medical Technologies (Nasdaq: KMTS), ein Unternehmen für tragbare medizinische Geräte und digitale Gesundheitsversorgung, hat die Bekanntgabe seiner finanziellen Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 auf Montag, den 14. April festgelegt. Das Unternehmen wird um 16:30 Uhr Eastern Time / 13:30 Uhr Pacific Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können sowohl auf die Live- als auch auf die archivierte Version des Webcasts über den Bereich 'Veranstaltungen' der Investor-Relations-Website zugreifen, wobei eine Registrierung mindestens 10 Minuten vor dem Anruf empfohlen wird.
- None.
- None.
KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on Monday, April 14. Management will host a corresponding conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.
A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website. Participants are encouraged to register on the website at least 10 minutes prior to the start of the conference call.
About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.
Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com
FAQ
When will Kestra Medical Technologies (KMTS) release Q3 2025 earnings?
What time is the KMTS Q3 2025 earnings conference call?
How can investors access KMTS Q3 2025 earnings call?
What is the registration requirement for KMTS Q3 2025 earnings call?
